Breastcancer-genetics
2011 – 2020 of 2274
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2001
-
Mark
S-phase fraction and urokinase plasminogen activator are better markers for distant recurrences than Nottingham Prognostic Index and histologic grade in a prospective study of premenopausal lymph node-negative breast cancer
(
- Contribution to journal › Article
-
Mark
Carrying large fuel loads during sustained bird flight is cheaper than expected
(
- Contribution to journal › Article
-
Mark
Different roles of spermine in glucocorticoid- and Fas-induced apoptosis
(
- Contribution to journal › Article
-
Mark
BRCA2 mutation in a family with hereditary prostate cancer
(
- Contribution to journal › Article
-
Mark
Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families
(
- Contribution to journal › Article
-
Mark
Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer
(
- Contribution to journal › Article
-
Mark
Survival in patients with intermediate or high grade non-Hodgkin's lymphoma: meta-analysis of randomized studies comparing third generation regimens with CHOP
(
- Contribution to journal › Article
-
Mark
Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families
(
- Contribution to journal › Article
-
Mark
Frequent somatic loss of BRCA1 in breast tumours from BRCA2 germ-line mutation carriers and vice versa
(
- Contribution to journal › Article
-
Mark
Two BRCA1-positive epithelial ovarian tumors with metastases to the central nervous system: a case report
(
- Contribution to journal › Article